Overview

Stroke With Transfusions Changing to Hydroxyurea

Status:
Terminated

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare standard therapy (transfusions and chelation) with alternative therapy (hydroxyurea and phlebotomy) for the prevention of secondary stroke and management of iron overload in children with sickle cell anemia (SCA).

Phase:

Phase 3

Details

Lead Sponsor:

St. Jude Children's Research Hospital

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Hydroxyurea